Sunday 15 Jun, 2025 08:43 AM
Site map | Locate Us | Login
   Lemon Tree Hotels signs new property in Arunachal Pradesh    Adani Enterprises arm incorporates wholly owned subsidiary    Syngene's Bengaluru-based facility gets 'NAi' status from US FDA    NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit    Arkade Developers acquires 6.28 acre land in Thane; targets Rs 2000 cr GDV    NTPC to raise Rs 4,000 cr via 10-Year NCDs at 6.89%    Diamond Power Infra secures new orders worth Rs 117-cr    RPP Infra gains on bagging Rs 283-cr LoA from UPSIDA Kanpur    GTL Infrastructure Ltd leads losers in 'A' group    Balu Forge Industries Ltd leads losers in 'B' group    Coal India sets up CIL Rajasthan Akshay Urja subsidiary for renewable energy    Jyoti Resins incorporates new WOS, Jyoti Social Welfare Foundation    Volumes soar at Jubilant Ingrevia Ltd counter    Crisil Ratings reaffirms 'A/A1+' ratings of Heranba Industries with 'stable' outlook    Infomerics Rating reaffirms 'BBB+' rating of Sterling and Wilson Renewable 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Syngene's Bengaluru-based facility gets 'NAi' status from US FDA
14-Jun-25   14:28 Hrs IST

The inspection concluded successfully, with the facility found to be in compliance with the required regulations.

The inspection resulted in zero observations and no Form 483 was issued. The inspection has been classified as 'no action indicated' (NAI).

'The company remains commitment to high operating standards and rigorous compliance with global regulatory requirements across all its operations,' Syngene said in a statement.

Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.

On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 crore while net sales rose 11.03% to Rs 1018 crore in Q4 March 2025 over Q4 March 2024.

The scrip had lost 1.57% to end at Rs 652.50 on the BSE on Friday.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 41955188
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited